Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Ottawa

$31,000.00

Deciphering the Regulation and Functional Mechanisms of the Type Three Secretion Apparatus

FY 2020-21

Summary
Many bacterial pathogens affecting crops, livestock and humans use secretion systems to deliver potent virulence factors to their host. One of the most prevalent is the Type Three Secretion System (T3SS). T3SS are constituted of proteins acting as transcription regulators, chaperones and effectors, and of a syringe-like nanomachine known as the Type Three Secretion Apparatus (T3SA), which transfer effectors upon contacting host cells. The latter phenomenon is the key element of the virulence potential of many human enteropathogens (e.g. Salmonella spp., Yersinia enterecolitica, enteropathogenic Escherichia coli and Shigella spp.), which are collectively responsible for hundreds of millions of cases worldwide each year. Despite its importance, many basic aspects of T3SA function are still largely unknown. Indeed, a detailed dynamic view of T3SA assembly and functional mechanisms is most acutely lacking to efficiently exploit this structural knowledge in order to develop novel anti-infectious agents. Raising concerns of antibiotic resistance and infectious diseases resurgence or spreading due to global warming underline the importance of conducting these research efforts. The current research proposal is aiming to be part of these by developing cutting-edge methods to monitor T3SA activity and shedding light on the dynamic nature of T3SA inner workings, using Shigella as a model. We will monitor T3SA activity in real-time using a variety of luminescent, fluorescent and tagging assays that will take advantage of genetic and structural data about Shigella T3SA. For example, we will establish an in situ enzyme-based biotin labeling strategy to map protein-protein complexes that are formed at the export apparatus of inactive versus active T3SA. This data will be harnessed to obtain a dynamic view of T3SA mechanisms. To do this, Förster Resonance Energy Transfer (FRET) assays will be designed to monitor T3SA activity in real-time and pave the way to the identification of molecular cues leading to T3SA activation and inactivation. Building on our recent progress in monitoring T3SA activity using the fluorescent Transcription-based Secretion Activity Reporter (fluoTSAR), we will identify T3SS-unrelated proteins implicated in T3SA assembly and develop a luminescent assay tailored to screen genetic and small-molecules libraries for T3SA inhibitors. Since pharmacologically targeting T3SA activity represents a promising replacement for antibiotic therapy currently used to treat these bacterial infections, numerous applications will emerge from our fundamental research activities. Milestones that will be reached in this funding period and high impact publications stemming from it will provide a solid foundation for my research program. Trainees implicated will acquire technical and intellectual skills tailored for a wealth of different career in the public and private sectors.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2016-05587
Name nom
Campbell-Valois, François-Xavier
Department département
Chemistry and Biomolecular Sciences
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2016
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Installment
inst:5-6
Partie
2
Nb partie
6
Application title
Deciphering the Regulation and Functional Mechanisms of the Type Three Secretion Apparatus
Keyword
NSERC
Application summary
Many bacterial pathogens affecting crops, livestock and humans use secretion systems to deliver potent virulence factors to their host. One of the most prevalent is the Type Three Secretion System (T3SS). T3SS are constituted of proteins acting as transcription regulators, chaperones and effectors, and of a syringe-like nanomachine known as the Type Three Secretion Apparatus (T3SA), which transfer effectors upon contacting host cells. The latter phenomenon is the key element of the virulence potential of many human enteropathogens (e.g. Salmonella spp., Yersinia enterecolitica, enteropathogenic Escherichia coli and Shigella spp.), which are collectively responsible for hundreds of millions of cases worldwide each year. Despite its importance, many basic aspects of T3SA function are still largely unknown. Indeed, a detailed dynamic view of T3SA assembly and functional mechanisms is most acutely lacking to efficiently exploit this structural knowledge in order to develop novel anti-infectious agents. Raising concerns of antibiotic resistance and infectious diseases resurgence or spreading due to global warming underline the importance of conducting these research efforts. The current research proposal is aiming to be part of these by developing cutting-edge methods to monitor T3SA activity and shedding light on the dynamic nature of T3SA inner workings, using Shigella as a model. We will monitor T3SA activity in real-time using a variety of luminescent, fluorescent and tagging assays that will take advantage of genetic and structural data about Shigella T3SA. For example, we will establish an in situ enzyme-based biotin labeling strategy to map protein-protein complexes that are formed at the export apparatus of inactive versus active T3SA. This data will be harnessed to obtain a dynamic view of T3SA mechanisms. To do this, Förster Resonance Energy Transfer (FRET) assays will be designed to monitor T3SA activity in real-time and pave the way to the identification of molecular cues leading to T3SA activation and inactivation. Building on our recent progress in monitoring T3SA activity using the fluorescent Transcription-based Secretion Activity Reporter (fluoTSAR), we will identify T3SS-unrelated proteins implicated in T3SA assembly and develop a luminescent assay tailored to screen genetic and small-molecules libraries for T3SA inhibitors. Since pharmacologically targeting T3SA activity represents a promising replacement for antibiotic therapy currently used to treat these bacterial infections, numerous applications will emerge from our fundamental research activities. Milestones that will be reached in this funding period and high impact publications stemming from it will provide a solid foundation for my research program. Trainees implicated will acquire technical and intellectual skills tailored for a wealth of different career in the public and private sectors.